Using in vivo animal models for studying SARS-CoV-2.
Camila B P Da CostaAna Claudia de Menezes CruzJulio Cesar Q PenhaHelena Carla CastroLuis E R Da CunhaNorman A RatcliffeRafael CisneFrancislene Juliana MartinsPublished in: Expert opinion on drug discovery (2021)
Studies have reported the use of nonhuman primates, ferrets, mice, Syrian hamsters, lagomorphs, mink, and zebrafish in experiments that aimed to understand the course of COVID-19 or test vaccines and other drugs. In contrast, the assays with animal hyperimmune sera have only been used in in vitro assays. Finding an animal that faithfully reproduces all the characteristics of the disease in humans is difficult. Some models may be more complex to work with, such as monkeys, or require genetic manipulation so that they can express the human ACE2 receptor, as in the case of mice. Although some models are more promising, possibly the use of more than one animal model represents the best scenario. Therefore, further studies are needed to establish an ideal animal model to help in the development of other treatment strategies besides vaccines.
Keyphrases
- sars cov
- high fat diet induced
- high throughput
- endothelial cells
- coronavirus disease
- respiratory syndrome coronavirus
- case control
- magnetic resonance
- genome wide
- magnetic resonance imaging
- angiotensin converting enzyme
- induced pluripotent stem cells
- type diabetes
- wild type
- metabolic syndrome
- contrast enhanced
- insulin resistance
- copy number
- skeletal muscle